SPONSOR
Yonsei University
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2
Conditions studied: Ischemic Heart DiseaseHER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract CancerBreast Cancer
Yonsei University is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Ischemic Heart Disease, HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer, Breast Cancer.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Yonsei University
How many clinical trials has Yonsei University sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Yonsei University, of which 3 are actively recruiting participants. These trials cover conditions including Ischemic Heart Disease, HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer, Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Yonsei University research focus on?
Yonsei University clinical trials span Ischemic Heart Disease, HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer, Breast Cancer. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Yonsei University clinical trial?
To participate in a Yonsei University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Yonsei University trials with current recruitment status updated daily.
Clinical Trials by Yonsei University
NCT05320926
Recruiting
Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial
Ischemic Heart Disease
NCT05749900 Phase 1, Phase 2
Recruiting
First-line Trastuzumab, Gemcitabine, Cisplatin and Nivolumab in Advanced HER2- Positive Biliary Tract Cancer: a Multicenter, Open-label, Single-arm Phase Ib/II Trial (HERBOT)
HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer
NCT06174363
Recruiting
Analgesic Efficacy of Maxigesic in Breast Cancer Surgery
Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology